...
首页> 外文期刊>Bioresource Technology: Biomass, Bioenergy, Biowastes, Conversion Technologies, Biotransformations, Production Technologies >Biotransformation of ginsenoside Rb1 to ginsenoside Rd by highly substrate-tolerant Paecilomyces bainier 229-7
【24h】

Biotransformation of ginsenoside Rb1 to ginsenoside Rd by highly substrate-tolerant Paecilomyces bainier 229-7

机译:人参皂苷Rb1通过高度底物耐受性拟青霉Bainier 229-7的生物转化

获取原文
获取原文并翻译 | 示例

摘要

Paecilomyces bainier 229-7 was obtained after UV irradiation for 8. min in the presence of 0.4% LiCl and selection on potato dextrose media containing 30. mg/mL saponin from Panax notoginseng leaves (SPNL). The mutant produces ginsenoside Rd from ginsenoside Rb1 with a bioconversion rate as high as 94.9% under optimized culture conditions in shake flasks when supplied with 20. mg/mL of SPNL. Scale-up in 10-L fermenter resulted in an 89% bioconversion rate. Ginsenoside Rd was purified from the culture medium by a macroporous resin with a chromatographic purity of 92.6%. These results suggest that P. bainier 229-7 could be useful for the preparation of ginsenoside Rd in the pharmaceutical industry.
机译:在0.4%LiCl的存在下,紫外线照射8分钟后,在含有30. mg / mL三七叶(SPNL)的30. mg / mL皂苷的马铃薯葡萄糖培养基上进行选择,获得Bainer 229-7。当在SP摇瓶中提供20 mg / mL SPNL时,在优化的培养条件下,该突变体从人参皂苷Rb1产生人参皂苷Rd,其生物转化率高达94.9%。在10升发酵罐中按比例放大可产生89%的生物转化率。人参皂苷Rd通过大孔树脂从色谱介质中纯化,色谱纯度为92.6%。这些结果表明,P。bainier 229-7可用于制药工业中的人参皂苷Rd的制备。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号